Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
Open Access
- 30 June 2016
- journal article
- Published by Elsevier in BBA Clinical
- Vol. 6, 76-81
Abstract
No abstract availableKeywords
Funding Information
- Ovarian Cancer Research Fund (258813)
This publication has 29 references indexed in Scilit:
- Paraneoplastic Thrombocytosis in Ovarian CancerNew England Journal of Medicine, 2012
- Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaquesThrombosis and Haemostasis, 2012
- Molecular Determinants of Phospholipid Synergy in Blood ClottingJournal of Biological Chemistry, 2011
- Lysophosphatidylcholine Pretreatment Reduces VLA-4 and P-Selectin–Mediated B16.F10 Melanoma Cell Adhesion In vitro and Inhibits Metastasis-Like Lung Invasion In vivoMolecular Cancer Therapeutics, 2011
- Lactadherin and clearance of platelet-derived microvesiclesBlood, 2009
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cellsNature Cell Biology, 2008
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X–prothrombin systemBlood Coagulation & Fibrinolysis, 2006
- The Effect of Membrane Composition on the Hemostatic BalanceBiochemistry, 1999
- Plasmin inhibition of platelet function and of arachidonic acid metabolism.Journal of Clinical Investigation, 1985